These results suggest that glioma can activate the immune response of glioma through CD4 T cells,CD8 T cells and macrophages, and regulate the metabolic reprogramming of glioma by reducing mtDNA content and enhancing glycolysis, which may be a new approach for effective treatment of glioma. The gene discussed is CD4; the disease is central nervous system cancer.